V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010789 | 190003242 | 1.81 | 83.4 | Palliative (P) | 2019-06-08 | 2019-06-25 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101446517 |
| 190010791 | 190003244 | 1.81 | 40.6 | null | 2016-04-09 | 2016-04-20 | POMB/ACE | 02 | null | DOXORUBICIN + METHOTREXATE | 100854769 |
| 190010797 | 190003245 | 1.81 | 69 | Curative (C) | 2017-06-13 | 2017-06-13 | BEP 3 day | 01 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101477224 |
| 190010800 | 190003247 | 1.61 | 44.4 | Curative (C) | 2017-03-22 | 2017-03-26 | FEC 60 or 75 | 02 | N | MPV | 100086834 |
| 190010801 | 190003248 | 1.66 | 49.4 | Palliative (P) | 2020-08-17 | 2020-08-20 | PAM x 2 pre-surgery (cycles 1&2) | Y | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101686542 |
| 190010804 | 190003249 | 1.52 | 115 | Curative (C) | 2017-12-21 | 2018-01-08 | Capecitabine + Oxaliplatin 21day | 02 | Y | TRIAL | 101725962 |
| 190010807 | 190003250 | null | null | null | null | 2020-02-22 | Dox + HD Mtx (post PAM) | null | null | DOXORUBICIN + IFOSFAMIDE | 100716707 |
| 190010809 | 190003252 | null | null | null | null | 2016-05-21 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101652159 |
| 190010810 | 190003253 | 1.58 | 105 | Palliative (P) | 2018-03-29 | 2018-03-29 | Cisplatin + Doxorubicin | 1 | N | CISPLATIN + DOXORUBICIN | 100170944 |
| 190010811 | 190003254 | null | null | null | null | 2018-12-24 | MIFAMURTIDE | null | null | MIFAMURTIDE | 100829305 |
| 190010814 | 190003255 | null | null | null | null | 2017-12-18 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101522010 |
| 190010819 | 190003256 | 0 | 17.7 | Palliative (P) | 2018-07-24 | 2018-07-24 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101493385 |
| 190010821 | 190003257 | 1.67 | 54.2 | Palliative (P) | 2018-03-30 | 2018-03-31 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | OST AI | 101548674 |
| 190010832 | 190003259 | null | null | null | null | 2019-08-06 | OST Euramos 1 Closed Trial - Ai | null | null | EW EUROEWING 2012 ARM A VIDE | 101359043 |
| 190010833 | 190003260 | null | null | null | null | 2020-01-19 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100527408 |
| 190010836 | 190003262 | null | null | null | null | 2019-01-18 | CARBOPLATIN + RT | null | null | DOXORUBICIN | 101859531 |
| 190010837 | 190003263 | 0 | 52.6 | Palliative (P) | 2018-07-25 | 2018-07-27 | OST Euramos 1 Closed Trial - AP | N | N | OST AP | 101586453 |
| 190010850 | 190003265 | 1.64 | 29.2 | Palliative (P) | 2018-08-05 | 2018-08-05 | Dox + HD Mtx (post PAM) | 02 | N | CARBOPLATIN + PACLITAXEL | 100033451 |
| 190010851 | 190003266 | null | null | null | null | 2018-12-13 | Carboplatin + Vinorelbine Oral | null | null | TRIAL UNSPECIFIED | 101024865 |
| 190010853 | 190003267 | 1.75 | 71.3 | Palliative (P) | 2017-03-09 | 2017-03-12 | CISPLATIN + DOXORUBICIN + METHOTREXATE | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100377460 |
| 190010854 | 190003268 | 1.68 | 74.2 | Curative (C) | 2017-12-21 | 2018-01-04 | MAP | 02 | Y | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100789276 |
| 190010858 | 190003269 | 0 | 64.8 | null | 2014-10-01 | 2014-10-11 | Trial Unspecified | 02 | null | CAV | 101419259 |
| 190010862 | 190003271 | null | null | null | null | 2018-10-17 | LANREOTIDE | null | null | EURO-EWING | 100176446 |
| 190010868 | 190003272 | null | 38 | Curative (C) | 2016-08-13 | 2016-08-14 | Dox + HD Mtx (post PAM) | null | Y | EW EUROEWING 2012 ARM A VIDE | 100206002 |
| 190010869 | 190003273 | null | null | null | null | 2019-07-02 | Cisplatin + Etoposide po&iv 3 day | null | null | DOXORUBICIN + METHOTREXATE | 100868666 |
| 190010872 | 190003274 | 1.56 | 48.6 | Adjuvant (A) | 2017-03-14 | 2017-03-17 | CVP R | 01 | N | EW EUROEWING 2012 ARM A VIDE | 101389407 |
| 190010881 | 190003275 | 1.53 | 73 | Curative (C) | 2018-12-09 | 2018-12-28 | MIFAMURTIDE | 02 | N | DOXORUBICIN + METHOTREXATE | 101581794 |
| 190010882 | 190003276 | 1.72 | 83.4 | Curative (C) | 2018-04-16 | 2018-04-23 | CARBOPLATIN + GEMCITABINE | 02 | Y | EURO-EWING | 101453003 |
| 190010886 | 190003277 | 1.75 | 58 | Neo-adjuvant (N) | 2017-12-22 | 2018-01-07 | Cetuximab + Radiotherapy Load | 02 | N | CISPLATIN + FLUOROURACIL | 100755118 |
| 190010887 | 190003278 | 1.37 | 26.8 | Palliative (P) | 2015-09-13 | 2015-09-24 | CISPLATIN + FLUOROURACIL | 02 | N | EURAMOS TRIAL | 101753075 |
| 190010888 | 190003279 | 1.83 | 59 | Palliative (P) | 2017-01-06 | 2017-01-14 | NIVOLUMAB | 02 | N | MAP | 101759564 |
| 190010891 | 190003281 | 1.59 | 76.1 | Neo-adjuvant (N) | 2016-01-17 | 2016-01-28 | EW EuroEwing 2012 Arm B VDC | 02 | null | EW EUROEWING 2012 ARM B VDC | 100671342 |
| 190010894 | 190003283 | 1.82 | 100.7 | Palliative (P) | 2019-03-27 | 2019-03-27 | Cisplatin + Radiotherapy | Y | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101135795 |
| 190010896 | 190003284 | null | null | null | null | 2018-03-14 | Bevacizumab+Carbo+Pacliaxel | null | null | PACLITAXEL | 100114573 |
| 190010903 | 190003285 | 1.71 | 69.3 | null | null | 2018-09-09 | CISPLATIN + ETOPOSIDE | null | null | NB HRNBL-1 COJEC IND COURSE A | 101580678 |
| 190010907 | 190003287 | 1.6 | null | Palliative (P) | 2019-02-06 | 2019-02-16 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101577867 |
| 190010914 | 190003289 | 1.58 | 86 | Adjuvant (A) | 2017-05-26 | 2017-05-31 | Docetaxel+Gemcitabine (no prior RT) | N | N | CARBOPLATIN + ETOPOSIDE | 101520353 |
| 190010918 | 190003290 | 1.58 | 105.8 | Adjuvant (A) | 2019-12-12 | 2019-12-12 | MAP | 02 | Y | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101306097 |
| 190010921 | 190003291 | 1.8 | 65 | null | 2019-02-26 | 2019-03-12 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 100443179 |
| 190000433 | 190003296 | null | null | null | null | 2017-11-02 | OST Euramos 1 Closed Trial - M | null | null | TRIAL UNSPECIFIED | 101790118 |
| 190000808 | 190003298 | 1.54 | 89.2 | Adjuvant (A) | 2019-11-12 | 2019-11-20 | LANREOTIDE | null | N | PACLITAXEL | 101186648 |
| 190000995 | 190003299 | 1.7 | 57.1 | Adjuvant (A) | 2019-12-11 | 2019-12-14 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101727079 |
| 190001340 | 190003300 | null | null | null | null | 2021-07-12 | NB HRNBL-1 COJEC Ind COURSE A | null | null | EURO-EWING | 101789122 |
| 190001777 | 190003301 | null | null | null | 2019-10-08 | 2019-10-08 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 100718931 |
| 190002470 | 190003302 | null | null | null | null | 2017-01-09 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101869251 |
| 190002742 | 190003303 | null | null | null | null | 2019-06-17 | PAM x 2 post-surgery (cycles 3&4) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100678585 |
| 190002755 | 190003304 | 0 | 61.4 | Curative (C) | 2016-09-15 | 2016-09-16 | OST Euramos 1 Closed Trial - AP | 02 | null | OST AP | 101342646 |
| 190003001 | 190003305 | null | null | null | null | 2018-10-09 | EURAMOS TRIAL | null | null | EURO-EWING | 101520261 |
| 190003411 | 190003306 | null | null | null | null | 2020-04-07 | CABOZANTINIB | null | null | LANREOTIDE | 100660791 |
| 190003454 | 190003307 | 1.68 | 28.8 | Curative (C) | 2016-03-24 | 2016-03-24 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100230226 |